Document Detail


Cytosine arabinoside induced liver damage: histopathologic demonstration.
MedLine Citation:
PMID:  6577264     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two patients with acute leukemia developed abnormal liver function tests after the administration of cytosine arabinoside. Other possible causes for such abnormalities were not likely. In both patients a close chronologic relationship between the administration of the drug and the appearance of the laboratory abnormalities was noted. The liver damage was also documented by biopsy. To our knowledge this is the first time that the hepatotoxic effects of cytosine arabinoside are histologically demonstrated.
Authors:
J Pizzuto; A Avilés; E Ramos; J Cervera; J Aguirre
Related Documents :
12944594 - Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: mr imaging...
14617394 - A novel technique to treat ruptured umbilical hernias in patients with liver cirrhosis ...
2857944 - Therapeutic embolisation of the hepatic artery: a review of 75 procedures.
10511174 - Primary sclerosing cholangitis: mr imaging findings with pathologic correlation.
304654 - Digoxin and congestive heart failure.
6113624 - Effect of chronic beta-adrenergic therapy on the human lymphocyte response to concanava...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Medical and pediatric oncology     Volume:  11     ISSN:  0098-1532     ISO Abbreviation:  Med. Pediatr. Oncol.     Publication Date:  1983  
Date Detail:
Created Date:  1983-10-08     Completed Date:  1983-10-08     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7506654     Medline TA:  Med Pediatr Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  287-90     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cytarabine / adverse effects*
Female
Humans
Leukemia, Myeloid, Acute / drug therapy*
Liver / drug effects*,  pathology
Middle Aged
Chemical
Reg. No./Substance:
147-94-4/Cytarabine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chronic myelomonocytic leukaemia in infancy: a case report.
Next Document:  Skeletal scintigraphy and radiography at onset of acute lymphocytic leukemia in children.